Morning Breakouts

Latest KFF Health News Stories

First Edition: March 11, 2010

Morning Briefing

Today’s early morning highlights from the major news organizations, including the latest on President Obama’s push for health reform and the developments on Capitol Hill surroundng the legislation.

Congress Works On Tariff-Lowering Legislation For Haiti As Preval Meets With U.S. Leaders In Washington

Morning Briefing

The Senate Finance Committee’s chair, Max Baucus (D-Mont.), and top Republican, Charles Grassley (Iowa), are working with colleagues in the House on legislation that would lower tariffs in an effort to help Haiti’s apparel industry and help the country recover from the major January earthquake, CQ Politics reports. “The bipartisan effort comes as Senate Finance leaders consider ramping up their work to broadly overhaul multiple U.S. trade preference programs, which lower or eliminate U.S. tariffs on a wide range of products from many developing countries,” according to the publication (3/9).

British Government, HIV/AIDS Advocates Warn Decreased Aid Budgets Could Lead To Reversals In HIV/AIDS Treatment Progress

Morning Briefing

Recent gains in the global fight against HIV/AIDS could be reversed as the “global economic downturn pinches poor countries’ budgets and donors show signs of backing away from their promise to provide universal access to AIDS treatment,” the British government together with Medecins Sans Frontieres (MSF) warned Tuesday, Reuters AlertNet reports.

WHO’s Updated Malaria Guidelines Include Rapid Diagnosis, New ACT

Morning Briefing

The WHO on Tuesday released new guidelines for the treatment of malaria, which recommend “parasitological testing before treatment begins” and add “a new artemisinin based combination treatment [ACT] to the list of prescribed drugs,” BMJ News reports. According to BMJ News, WHO’s guidelines are “expected to enhance earlier and accurate diagnosis, halt the emergence of drug resistance, and reduce the use of unnecessary treatment” (Zarocostas, 3/9).

GSK To Offer Flexible Drug Pricing In Middle-Income Countries

Morning Briefing

Drug maker GlaxoSmithKline (GSK) “plans to bolster earnings by selling to more people in middle-income countries after cutting prices in the world’s poorest nations,” Bloomberg/BusinessWeek reports.